The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural Basis for the Effective Myostatin Inhibition of the Mouse Myostatin Prodomain-Derived Minimum Peptide.EBI
Tokyo University of Pharmacy and Life Sciences
Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonate.EBI
Tokyo University of Pharmacy and Life Sciences
Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.EBI
Tokyo University of Pharmacy and Life Sciences
Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.EBI
Tokyo University of Pharmacy and Life Sciences
Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.EBI
Tokyo University of Pharmacy and Life Sciences
Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structure.EBI
Tokyo University of Pharmacy and Life Sciences
Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs.EBI
Tokyo University of Pharmacy and Life Sciences
Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP.EBI
Tokyo University of Pharmacy and Life Sciences
Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice.EBI
Tokyo University of Pharmacy and Life Sciences
Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.EBI
Tokyo University of Pharmacy and Life Sciences
A chemically stable peptide agonist to neuromedin U receptor type 2.EBI
Tokyo University of Pharmacy and Life Sciences
Selective acetylcholinesterase inhibitors derived from muscle relaxant dantrolene.EBI
Tokyo University of Pharmacy and Life Sciences
Discovery of a follistatin-derived myostatin inhibitory peptide.EBI
Tokyo University of Pharmacy and Life Sciences
Design and synthesis of potent myostatin inhibitory cyclic peptides.EBI
Tokyo University of Pharmacy and Life Sciences
Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice.EBI
Tokyo University of Pharmacy and Life Sciences
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.EBI
Tokyo University of Pharmacy and Life Sciences
Tubulin photoaffinity labeling study with a plinabulin chemical probe possessing a biotin tag at the oxazole.EBI
Tokyo University of Pharmacy and Life Sciences
Anti-microtubule 'plinabulin' chemical probe KPU-244-B3 labeled both alpha- and beta-tubulin.EBI
Tokyo University of Pharmacy and Life Sciences
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification.EBI
Tokyo University of Pharmacy and Life Sciences
Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.EBI
Tokyo University of Pharmacy and Life Sciences